Retatrutide interactions that may occur include insulin, oral diabetes medications, and medicines that influence digestion
Earlier studies suggest that semaglutide (sold as Ozempic, Wegovy, and Rybelsus) may cause more digestive issues, including diarrhea, than older GLP-1 medications like liraglutide (Saxenda and Victoza)
In a 3-month randomized controlled study of type 2 diabetes, it was found that the combination of liraglutide and sitagliptin had no effect on the composition of intestinal flora, had no effect on the alpha and beta diversity, but liraglutide resulted in an elevation of deoxycholic acid (DCA) levels, indicating potential modulation of bile acid metabolism (Smits et al., 2021)
Weighing Maternal Health Benefits Against Theoretical Risk Untreated obesity during the postpartum period increases maternal risks for type 2 diabetes, cardiovascular disease, and depressionconditions that directly affect breastfeeding success, mood stability, and overall infant care capacity
Contact: Molly Molendyke [email protected]
Frequently asked questions (FAQs) No, GLP-1 is not the same as Ozempic, but Ozempic is a type of GLP-1 medication